• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本轻至中度血友病 A 患者的基因型和表型特征。

Genotypic and phenotypic features of Japanese patients with mild to moderate hemophilia A.

机构信息

Department of Laboratory Medicine, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, Japan.

出版信息

Int J Hematol. 2013 Jun;97(6):758-64. doi: 10.1007/s12185-013-1341-9. Epub 2013 Apr 27.

DOI:10.1007/s12185-013-1341-9
PMID:23625609
Abstract

Hemophilia A is the most common inherited bleeding disorder. To better understand the genotypic and phenotypic features of Japanese patients with mild to moderate hemophilia A, we studied 29 unrelated patients with more than 1 % FVIII activity (FVIII:C). Differences were observed in nine of 21 patients in measured FVIII:C levels between the one-stage clotting and chromogenic assays. We identified a mutation in F8 in 28 of the 29 patients. Mutations in two amino acids, Y492 and R550, were detected at a much higher frequency in our patients than in the international hemophilia A mutation database. We demonstrated that all five patients with the Y492C mutation have an identical F8 haplotype that is unique to them, suggesting that the mutation may have originated from a common ancestor. Because non-severe, moderate to mild, hemophilia patients have a longer lifespan, mutations that cause non-severe phenotypes tend to persist in the population. We believe that the Y492C mutation is a distinctive feature of Japanese patients with mild hemophilia A. The identification of a high frequency of R550 mutation that underlies the discrepancies in FVIII:C measurements in the present study suggests that Japanese patients with mild hemophilia may require careful characterization.

摘要

血友病 A 是最常见的遗传性出血性疾病。为了更好地了解日本轻至中度血友病 A 患者的基因型和表型特征,我们研究了 29 名 FVIII:C 活性超过 1%的无亲缘关系患者。在 21 名患者中,有 9 名患者在一期凝固和显色测定法中测量的 FVIII:C 水平存在差异。我们在 29 名患者中的 28 名中鉴定了 F8 中的突变。在我们的患者中,两个氨基酸 Y492 和 R550 的突变比国际血友病 A 突变数据库中的突变频率高得多。我们证明,所有 5 名 Y492C 突变患者都具有独特的、相同的 F8 单倍型,表明该突变可能起源于一个共同的祖先。由于非重度、中度至轻度血友病患者的寿命更长,导致非重度表型的突变往往在人群中持续存在。我们认为 Y492C 突变是日本轻度血友病 A 患者的一个特征。本研究中 FVIII:C 测量差异的基础上 R550 突变的高频出现表明,日本轻度血友病患者可能需要仔细的特征描述。

相似文献

1
Genotypic and phenotypic features of Japanese patients with mild to moderate hemophilia A.日本轻至中度血友病 A 患者的基因型和表型特征。
Int J Hematol. 2013 Jun;97(6):758-64. doi: 10.1007/s12185-013-1341-9. Epub 2013 Apr 27.
2
Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations.在携带相同 F8 突变的轻度/中度血友病 A 患者的回顾性队列中,基线因子 VIII 浓度的变化。
J Thromb Haemost. 2017 Feb;15(2):246-254. doi: 10.1111/jth.13581. Epub 2017 Feb 3.
3
Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.轻度甲型血友病患者及FVIII测量结果不一致时的诊断与管理挑战
Haemophilia. 2014 Jul;20(4):550-8. doi: 10.1111/hae.12381. Epub 2014 Feb 12.
4
Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays.伴有凝血因子 VIII 一期法和显色法检测结果差异的轻中度血友病 A 患者的遗传学和止血潜能。
Thromb Haemost. 2021 Jan;121(1):27-35. doi: 10.1055/s-0040-1715443. Epub 2020 Aug 13.
5
Prevalence, biological phenotype and genotype in moderate/mild hemophilia A with discrepancy between one-stage and chromogenic factor VIII activity.一期法和显色因子 VIII 活性检测结果不一致的轻中度血友病 A 的流行率、生物学表型和基因型。
J Thromb Haemost. 2011 Mar;9(3):524-30. doi: 10.1111/j.1538-7836.2010.04174.x.
6
Cross-reacting Material-positive Hemophilia A Diagnosed in a Patient with a Spontaneous Thigh Hemorrhage.在一名自发性大腿出血患者中诊断出交叉反应物质阳性的甲型血友病。
Intern Med. 2017;56(13):1719-1723. doi: 10.2169/internalmedicine.56.7487. Epub 2017 Jul 1.
7
Phenotype-genotype correlations in hemophilia A carriers are consistent with the binary role of the phase between F8 and X-chromosome inactivation.血友病 A 携带者的表型-基因型相关性与 F8 和 X 染色体失活之间的相位的二元作用一致。
J Thromb Haemost. 2015 Apr;13(4):530-9. doi: 10.1111/jth.12854. Epub 2015 Mar 14.
8
Identification of seven novel mutations in the factor VIII gene in 18 unrelated Chinese patients with hemophilia A.鉴定 18 例非相关中国血友病 A 患者凝血因子 VIII 基因中的 7 种新型突变。
Chin Med J (Engl). 2010 Feb 5;123(3):305-10.
9
Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays.在一期、二期和显色因子 VIII:C 测定结果不一致的轻度血友病 A 患者中进行诊断性检测。
Semin Thromb Hemost. 2013 Apr;39(3):272-82. doi: 10.1055/s-0033-1334863. Epub 2013 Mar 4.
10
Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.严重血友病伴轻度出血表型:分子特征和全球凝血谱。
J Thromb Haemost. 2010 Apr;8(4):737-43. doi: 10.1111/j.1538-7836.2010.03767.x. Epub 2009 Jan 21.

本文引用的文献

1
Assay discrepancy in mild haemophilia A: entire population study in a National Haemophilia Centre.轻度甲型血友病的检测差异:在一家国家血友病中心进行的全人群研究
Haemophilia. 2009 Jan;15(1):285-9. doi: 10.1111/j.1365-2516.2008.01899.x.
2
Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex.人凝血因子VIII的晶体结构:对凝血因子IXa-凝血因子VIIIa复合物形成的影响
Structure. 2008 Apr;16(4):597-606. doi: 10.1016/j.str.2008.03.001.
3
Screening of mutations of hemophilia A in 40 Italian patients: a novel G-to-A mutation in intron 10 of the F8 gene as a putative cause of mild hemophilia A in southern Italy.
40例意大利患者血友病A突变筛查:F8基因内含子10中一种新的G到A突变可能是意大利南部轻度血友病A的病因。
Blood Coagul Fibrinolysis. 2008 Apr;19(3):197-202. doi: 10.1097/MBC.0b013e3282f234ab.
4
A recurrent F8 mutation in Irish haemophilia A patients: evidence for a founder effect.爱尔兰甲型血友病患者中F8基因的复发性突变:奠基者效应的证据。
Haemophilia. 2008 Mar;14(2):394-5. doi: 10.1111/j.1365-2516.2007.01639.x. Epub 2007 Dec 28.
5
Discrepant factor VIII activity in a family with mild haemophilia A and 531 mutation using various FVIII assays and APTT reagents.
Haemophilia. 2005 Sep;11(5):561-4. doi: 10.1111/j.1365-2516.2005.01122.x.
6
Spectrum of molecular defects and mutation detection rate in patients with severe hemophilia A.重度甲型血友病患者的分子缺陷谱及突变检测率
Hum Mutat. 2005 Sep;26(3):249-54. doi: 10.1002/humu.20208.
7
A founder factor VIII mutation, valine 2016 to alanine, in a population with an extraordinarily high prevalence of mild hemophilia A.在轻度甲型血友病患病率极高的人群中发现的一种VIII因子突变,缬氨酸2016突变为丙氨酸。
Thromb Haemost. 2002 Jan;87(1):178-9.
8
Rapid hemophilia A molecular diagnosis by a simple DNA sequencing procedure: identification of 14 novel mutations.通过简单的DNA测序程序进行血友病A的快速分子诊断:鉴定14个新突变
Thromb Haemost. 2001 Apr;85(4):580-3.
9
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.血友病的定义。国际血栓与止血协会科学与标准化委员会第八因子和第九因子科学小组委员会的建议。
Thromb Haemost. 2001 Mar;85(3):560.
10
Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa.与一期/二期活性差异相关的甲型血友病突变破坏了凝血酶激活的因子VIIIa三联A结构域内的蛋白质-蛋白质相互作用。
Blood. 2001 Feb 1;97(3):685-91. doi: 10.1182/blood.v97.3.685.